chr7-147343214-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000361727.8(CNTNAP2):​c.1498+42924G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.637 in 151,928 control chromosomes in the GnomAD database, including 31,794 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.64 ( 31794 hom., cov: 32)

Consequence

CNTNAP2
ENST00000361727.8 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.227

Publications

3 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.8 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000361727.8. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
NM_014141.6
MANE Select
c.1498+42924G>A
intron
N/ANP_054860.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
ENST00000361727.8
TSL:1 MANE Select
c.1498+42924G>A
intron
N/AENSP00000354778.3
CNTNAP2
ENST00000636870.1
TSL:5
n.1360+42924G>A
intron
N/A
CNTNAP2
ENST00000637694.1
TSL:5
n.1401+42924G>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.637
AC:
96668
AN:
151808
Hom.:
31761
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.808
Gnomad AMI
AF:
0.595
Gnomad AMR
AF:
0.587
Gnomad ASJ
AF:
0.547
Gnomad EAS
AF:
0.417
Gnomad SAS
AF:
0.563
Gnomad FIN
AF:
0.570
Gnomad MID
AF:
0.490
Gnomad NFE
AF:
0.584
Gnomad OTH
AF:
0.566
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.637
AC:
96747
AN:
151928
Hom.:
31794
Cov.:
32
AF XY:
0.633
AC XY:
46969
AN XY:
74240
show subpopulations
African (AFR)
AF:
0.807
AC:
33476
AN:
41478
American (AMR)
AF:
0.587
AC:
8944
AN:
15232
Ashkenazi Jewish (ASJ)
AF:
0.547
AC:
1894
AN:
3464
East Asian (EAS)
AF:
0.418
AC:
2159
AN:
5160
South Asian (SAS)
AF:
0.562
AC:
2703
AN:
4808
European-Finnish (FIN)
AF:
0.570
AC:
6021
AN:
10566
Middle Eastern (MID)
AF:
0.493
AC:
145
AN:
294
European-Non Finnish (NFE)
AF:
0.584
AC:
39679
AN:
67906
Other (OTH)
AF:
0.562
AC:
1185
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1700
3400
5099
6799
8499
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
778
1556
2334
3112
3890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.587
Hom.:
19709
Bravo
AF:
0.644
Asia WGS
AF:
0.478
AC:
1665
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
3.2
DANN
Benign
0.54
PhyloP100
0.23
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1404699; hg19: chr7-147040306; API